Jun 30, 2025 08:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 08:33AM
Jun 25, 2025 08:30AM
Jun 23, 2025 08:30AM
Jun 18, 2025 02:04PM
Jun 17, 2025 02:57PM Eyenovia (EYEN) Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
Jun 17, 2025 02:55PM
Jun 4, 2025 08:45AM
May 19, 2025 05:34PM
May 19, 2025 05:30PM
Mar 20, 2025 07:00AM
Jan 6, 2025 07:01AM
Jan 6, 2025 07:00AM Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives
Nov 22, 2024 07:00AM
Nov 22, 2024 07:00AM
Nov 15, 2024 07:00AM
Nov 15, 2024 07:00AM
Sep 3, 2024 07:02AM
Sep 3, 2024 07:00AM
Apr 8, 2024 07:02AM Eyenovia Inc (EYEN) Announces Updated Strategy and Corporate Priorities
Apr 8, 2024 07:00AM
Jan 16, 2024 07:03AM
Jan 16, 2024 07:00AM
Nov 13, 2023 04:05PM
Aug 16, 2023 06:01AM
Aug 16, 2023 06:00AM
Aug 16, 2023 06:00AM Eyenovia Acquires U.S. Commercial Rights to APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension, 0.05%) from Formosa Pharmaceuticals

1,188,121 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All